Marvin Donald
CIK 0001891264
Executive VP, CFO & COO
Filings
2
Latest Jun 21, 2022
Issuers covered
1
Showing
2 of 2
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 71% | -1.4% | +2.3% | +2.3% | -10.5% |
| 90 days | 7 | 0% | -17.0% | -15.4% | -15.4% | -21.0% |
| 180 days | 7 | 0% | -14.7% | -13.4% | -13.4% | -17.9% |
| 365 days | 7 | 0% | -62.8% | -62.5% | -62.5% | -63.7% |
Issuers
Companies where Marvin Donald has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd. | 2 | Jun 21, 2022 |
All filings
2 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|